AU760537B2 - Particulate delivery systems and methods of use - Google Patents

Particulate delivery systems and methods of use Download PDF

Info

Publication number
AU760537B2
AU760537B2 AU35469/99A AU3546999A AU760537B2 AU 760537 B2 AU760537 B2 AU 760537B2 AU 35469/99 A AU35469/99 A AU 35469/99A AU 3546999 A AU3546999 A AU 3546999A AU 760537 B2 AU760537 B2 AU 760537B2
Authority
AU
Australia
Prior art keywords
microstructures
group
combinations
enhanced
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU35469/99A
Other languages
English (en)
Other versions
AU760537C (en
AU3546999A (en
Inventor
Adrian I. Bot
Luis A. Dellamary
Alexey Kabalnov
Ernest G. Schutt
Thomas E. Tarara
Jeffry G. Weers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Inhale Therapeutics Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27557723&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU760537(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US1998/020613 external-priority patent/WO1999016421A1/en
Priority claimed from PCT/US1998/020603 external-priority patent/WO1999016420A1/en
Priority claimed from US09/218,213 external-priority patent/US6946117B1/en
Priority claimed from US09/219,736 external-priority patent/US6565885B1/en
Priority claimed from US09/218,212 external-priority patent/US6309623B1/en
Priority claimed from US09/218,209 external-priority patent/US6433040B1/en
Application filed by Inhale Therapeutics Systems Inc filed Critical Inhale Therapeutics Systems Inc
Priority claimed from PCT/US1999/006855 external-priority patent/WO2000000215A1/en
Application granted granted Critical
Publication of AU760537C publication Critical patent/AU760537C/en
Publication of AU3546999A publication Critical patent/AU3546999A/en
Publication of AU760537B2 publication Critical patent/AU760537B2/en
Assigned to NEKTAR THERAPEUTICS reassignment NEKTAR THERAPEUTICS Alteration of Name(s) of Applicant(s) under S113 Assignors: INHALE THERAPEUTIC SYSTEMS, INC.
Assigned to NOVARTIS AG reassignment NOVARTIS AG Alteration of Name(s) in Register under S187 Assignors: NEKTAR THERAPEUTICS
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Powder Metallurgy (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU35469/99A 1998-06-29 1999-03-31 Particulate delivery systems and methods of use Ceased AU760537B2 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US10693298A 1998-06-29 1998-06-29
US09/106932 1998-06-29
US13384898A 1998-08-14 1998-08-14
US09/133848 1998-08-14
AUPCT/US1998/020602 1998-09-29
PCT/US1998/020613 WO1999016421A1 (en) 1997-09-29 1998-09-29 Stabilized bioactive preparations and methods of use
AUPCT/US1998/020613 1998-09-29
PCT/US1998/020615 WO1999016422A1 (en) 1997-09-29 1998-09-29 Stabilized preparations for use in metered dose inhalers
AUPCT/US1998/020603 1998-09-29
AUPCT/US1998/020615 1998-09-29
PCT/US1998/020602 WO1999016419A1 (en) 1997-09-29 1998-09-29 Perforated microparticles and methods of use
PCT/US1998/020603 WO1999016420A1 (en) 1997-09-29 1998-09-29 Stabilized preparations for use in nebulizers
US09/218,213 US6946117B1 (en) 1997-09-29 1998-12-22 Stabilized preparations for use in nebulizers
US09/218212 1998-12-22
US09/219,736 US6565885B1 (en) 1997-09-29 1998-12-22 Methods of spray drying pharmaceutical compositions
US09/218,212 US6309623B1 (en) 1997-09-29 1998-12-22 Stabilized preparations for use in metered dose inhalers
US09/218209 1998-12-22
US09/218213 1998-12-22
US09/218,209 US6433040B1 (en) 1997-09-29 1998-12-22 Stabilized bioactive preparations and methods of use
US09/219736 1998-12-22
PCT/US1999/006855 WO2000000215A1 (en) 1998-06-29 1999-03-31 Particulate delivery systems and methods of use

Publications (3)

Publication Number Publication Date
AU760537C AU760537C (en) 2000-01-17
AU3546999A AU3546999A (en) 2000-01-17
AU760537B2 true AU760537B2 (en) 2003-05-15

Family

ID=27557723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35469/99A Ceased AU760537B2 (en) 1998-06-29 1999-03-31 Particulate delivery systems and methods of use

Country Status (5)

Country Link
EP (1) EP1091755A1 (ko)
JP (1) JP2003535017A (ko)
KR (1) KR100796220B1 (ko)
AU (1) AU760537B2 (ko)
CA (1) CA2335940A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1750668B1 (en) * 2004-04-13 2010-02-17 Nova Bio-Pharma Technologies Limited Liquids containing suspended glass particles
GB0408164D0 (en) * 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
US20100226990A1 (en) * 2006-01-27 2010-09-09 The Provost, Fellows And Scholars Of The College O Method of Producing Porous Microparticles
CN105944095B (zh) * 2008-03-05 2021-04-02 赛诺菲巴斯德有限公司 一种使含佐剂的疫苗组合物稳定的方法
KR20120132183A (ko) * 2011-05-27 2012-12-05 포항공과대학교 산학협력단 종양 조직에서 유래한 나노소포체 및 이를 이용한 암 백신
CN102384973B (zh) * 2011-08-10 2014-09-10 华南理工大学 快速定量检测羟甲基糠醛的免疫层析试纸条及其制备方法
US9427376B2 (en) * 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016419A1 (en) * 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Perforated microparticles and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016419A1 (en) * 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Perforated microparticles and methods of use
AU757337B2 (en) * 1997-09-29 2003-02-20 Novartis Ag Perforated microparticles and methods of use

Also Published As

Publication number Publication date
AU760537C (en) 2000-01-17
KR100796220B1 (ko) 2008-01-21
EP1091755A1 (en) 2001-04-18
AU3546999A (en) 2000-01-17
CA2335940A1 (en) 2000-01-06
KR20010053299A (ko) 2001-06-25
JP2003535017A (ja) 2003-11-25

Similar Documents

Publication Publication Date Title
US6630169B1 (en) Particulate delivery systems and methods of use
WO2000000215A1 (en) Particulate delivery systems and methods of use
JP6078498B2 (ja) 計量吸入器における使用のための安定化調製物
US7306787B2 (en) Engineered particles and methods of use
US6638495B2 (en) Stabilized preparation for use in metered dose inhalers
US20070065369A1 (en) Novel methods and composition for delivering macromolecules to or via the respiratory tract
AU760537B2 (en) Particulate delivery systems and methods of use
US20040213745A1 (en) Powder formulations of rSEB for improved vaccination
JP2003535017A5 (ko)
Mossadeq et al. Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs
US7141236B2 (en) Methods and compositions for delivering macromolecules to or via the respiratory tract
MXPA00012613A (en) Particulate delivery systems and methods of use
JP2004528339A (ja) 気道に対して又は気道を介して高分子を送達するための新規方法及び組成物
MXPA00003103A (en) Stabilized preparations for use in nebulizers
MXPA00003096A (en) Stabilized preparations for use in metered dose inhalers
MXPA00003105A (en) Perforated microparticles and methods of use

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: NEKTAR THERAPEUTICS

Free format text: THE FORMER OWNER WAS: INHALE THERAPEUTIC SYSTEMS, INC.

CB Opposition lodged by

Opponent name: ALKERMES, INC.

ON Decision of a delegate or deputy of the commissioner of patents (result of patent office hearing)

Free format text: NONE OF THE CITATIONS DEPRIVED ANY OF THE CLAIMS OF THEIR INVENTIVE STEP.

Opponent name: ALKERMES, INC.

Effective date: 20071218